Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study-Reference-Cited by-同舟云学术

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

Published:2019-10 Issue:10207 Volume:394 Page:1437-1449
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chinthrajah R Sharon,Purington Natasha,Andorf Sandra,Long Andrew,O'Laughlin Katherine L,Lyu Shu Chen,Manohar Monali,Boyd Scott D,Tibshirani Robert,Maecker Holden,Plaut Marshall,Mukai Kaori,Tsai Mindy,Desai Manisha,Galli Stephen J,Nadeau Kari C

Funder

NIAID

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. The prevalence, severity, and distribution of childhood food allergy in the United States;Gupta;Pediatrics,2011

2. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel;Boyce;J Allergy Clin Immunol,2010

3. Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy;Cherkaoui;Clin Transl Allergy,2015

4. Oral immunotherapy for food allergies;Feuille;Ann Nutr Metab,2016

5. AR101 Oral Immunotherapy for Peanut Allergy;N Engl J Med,2018

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of cytotoxic effector memory CD8⁺ T cells with sustained unresponsiveness after peanut oral immunotherapy;Allergy;2024-09-07

2. Atopic dermatitis and IgE-mediated food allergy;Annals of Allergy, Asthma & Immunology;2024-09

3. Peanut oral immunotherapy protecting a young captive in Gaza from anaphylaxis;Annals of Allergy, Asthma & Immunology;2024-09

4. You do not get to choose your nightmares: They choose you;Annals of Allergy, Asthma & Immunology;2024-09

5. Whence and wherefore IgE?;Immunological Reviews;2024-07-23